Stomach Cancer Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Stomach Cancer Market to 2027 - Global Analysis and Forecasts by Therapy (Chemotherapy, Radiotherapy, Surgery, Targeted Therapy, Others); Healthcare Provider (Hospitals, Cancer Research Organizations, Cancer Treatment Centers) and Gepgraphy

Report Code: TIPRE00004053 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Stomach cancer is also known as gastric cancer, it is caused due to the abnormal growth of the malignant cells in the stomach. This can be caused due to age and diet may be developed risk of stomach cancer. The symptoms of the stomach cancer include indigestion and stomach discomfort, loss of appetite, heartburn, weightloss and others.

MARKET DYNAMICS
The stomach cancer market is witnessed to grow due to the rise in the incidences of gastrointestinal stromal tumors, lymphoma, adenocarcinoma and others. The growth is also driven by the advancement in the therapies and drug formulation and others. The significantly rising prevalence is likely to create growth opportunities for the market during the forecast period.

MARKET SCOPE
The "Global Stomach Cancer Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of stomach cancer market with detailed market segmentation by therapy, healthcare provider and geography. The global stomach cancer market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading stomach cancer market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global stomach cancer market is segmented on the basis of product and application. Based on the therapy market is classified as chemotherapy, radiotherapy, surgery, targeted therapy and others. On the basis of the healthcare provider it is segmented as hospitals, cancer research organizations and cancer treatment centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global stomach cancer market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The stomach cancer market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting stomach cancer market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the stomach cancer market in these regions.

MARKET PLAYERS
The reports cover key developments in the stomach cancer market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from stomach cancer market are anticipated to lucrative growth opportunities in the future with the rising demand for stomach cancer market in the global market. Below mentioned is the list of few companies engaged in the Stomach cancer market.

The report also includes the profiles of key stomach cancer market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Eli Lilly And Company
  • GlaxoSmithkline Plc
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • Novartis AG
  • Otsuka Holdings Co. Ltd
  • Bristol-Myers Squibb
  • Imugene Limited
  • Merck KGaA
  • Ono Pharmaceuticals
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Stomach Cancer Market - By Therapy
1.3.2 Stomach Cancer Market - By Healthcare Provider
1.3.3 Stomach Cancer Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. STOMACH CANCER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. STOMACH CANCER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. STOMACH CANCER MARKET - GLOBAL MARKET ANALYSIS
6.1. STOMACH CANCER - GLOBAL MARKET OVERVIEW
6.2. STOMACH CANCER - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. STOMACH CANCER MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. CHEMOTHERAPY
7.3.1. Overview
7.3.2. Chemotherapy Market Forecast and Analysis
7.4. RADIOTHERAPY
7.4.1. Overview
7.4.2. Radiotherapy Market Forecast and Analysis
7.5. SURGERY
7.5.1. Overview
7.5.2. Surgery Market Forecast and Analysis
7.6. TARGETED THERAPY
7.6.1. Overview
7.6.2. Targeted Therapy Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. STOMACH CANCER MARKET - REVENUE AND FORECASTS TO 2027 - HEALTHCARE PROVIDER
8.1. OVERVIEW
8.2. HEALTHCARE PROVIDER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CANCER RESEARCH ORGANIZATIONS
8.4.1. Overview
8.4.2. Cancer Research Organizations Market Forecast and Analysis
8.5. CANCER TREATMENT CENTERS
8.5.1. Overview
8.5.2. Cancer Treatment Centers Market Forecast and Analysis
9. STOMACH CANCER MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Stomach Cancer Market Overview
9.1.2 North America Stomach Cancer Market Forecasts and Analysis
9.1.3 North America Stomach Cancer Market Forecasts and Analysis - By Therapy
9.1.4 North America Stomach Cancer Market Forecasts and Analysis - By Healthcare Provider
9.1.5 North America Stomach Cancer Market Forecasts and Analysis - By Countries
9.1.5.1 United States Stomach Cancer Market
9.1.5.1.1 United States Stomach Cancer Market by Therapy
9.1.5.1.2 United States Stomach Cancer Market by Healthcare Provider
9.1.5.2 Canada Stomach Cancer Market
9.1.5.2.1 Canada Stomach Cancer Market by Therapy
9.1.5.2.2 Canada Stomach Cancer Market by Healthcare Provider
9.1.5.3 Mexico Stomach Cancer Market
9.1.5.3.1 Mexico Stomach Cancer Market by Therapy
9.1.5.3.2 Mexico Stomach Cancer Market by Healthcare Provider
9.2. EUROPE
9.2.1 Europe Stomach Cancer Market Overview
9.2.2 Europe Stomach Cancer Market Forecasts and Analysis
9.2.3 Europe Stomach Cancer Market Forecasts and Analysis - By Therapy
9.2.4 Europe Stomach Cancer Market Forecasts and Analysis - By Healthcare Provider
9.2.5 Europe Stomach Cancer Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Stomach Cancer Market
9.2.5.1.1 Germany Stomach Cancer Market by Therapy
9.2.5.1.2 Germany Stomach Cancer Market by Healthcare Provider
9.2.5.2 France Stomach Cancer Market
9.2.5.2.1 France Stomach Cancer Market by Therapy
9.2.5.2.2 France Stomach Cancer Market by Healthcare Provider
9.2.5.3 Italy Stomach Cancer Market
9.2.5.3.1 Italy Stomach Cancer Market by Therapy
9.2.5.3.2 Italy Stomach Cancer Market by Healthcare Provider
9.2.5.4 Spain Stomach Cancer Market
9.2.5.4.1 Spain Stomach Cancer Market by Therapy
9.2.5.4.2 Spain Stomach Cancer Market by Healthcare Provider
9.2.5.5 United Kingdom Stomach Cancer Market
9.2.5.5.1 United Kingdom Stomach Cancer Market by Therapy
9.2.5.5.2 United Kingdom Stomach Cancer Market by Healthcare Provider
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Stomach Cancer Market Overview
9.3.2 Asia-Pacific Stomach Cancer Market Forecasts and Analysis
9.3.3 Asia-Pacific Stomach Cancer Market Forecasts and Analysis - By Therapy
9.3.4 Asia-Pacific Stomach Cancer Market Forecasts and Analysis - By Healthcare Provider
9.3.5 Asia-Pacific Stomach Cancer Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Stomach Cancer Market
9.3.5.1.1 Australia Stomach Cancer Market by Therapy
9.3.5.1.2 Australia Stomach Cancer Market by Healthcare Provider
9.3.5.2 China Stomach Cancer Market
9.3.5.2.1 China Stomach Cancer Market by Therapy
9.3.5.2.2 China Stomach Cancer Market by Healthcare Provider
9.3.5.3 India Stomach Cancer Market
9.3.5.3.1 India Stomach Cancer Market by Therapy
9.3.5.3.2 India Stomach Cancer Market by Healthcare Provider
9.3.5.4 Japan Stomach Cancer Market
9.3.5.4.1 Japan Stomach Cancer Market by Therapy
9.3.5.4.2 Japan Stomach Cancer Market by Healthcare Provider
9.3.5.5 South Korea Stomach Cancer Market
9.3.5.5.1 South Korea Stomach Cancer Market by Therapy
9.3.5.5.2 South Korea Stomach Cancer Market by Healthcare Provider
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Stomach Cancer Market Overview
9.4.2 Middle East and Africa Stomach Cancer Market Forecasts and Analysis
9.4.3 Middle East and Africa Stomach Cancer Market Forecasts and Analysis - By Therapy
9.4.4 Middle East and Africa Stomach Cancer Market Forecasts and Analysis - By Healthcare Provider
9.4.5 Middle East and Africa Stomach Cancer Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Stomach Cancer Market
9.4.5.1.1 South Africa Stomach Cancer Market by Therapy
9.4.5.1.2 South Africa Stomach Cancer Market by Healthcare Provider
9.4.5.2 Saudi Arabia Stomach Cancer Market
9.4.5.2.1 Saudi Arabia Stomach Cancer Market by Therapy
9.4.5.2.2 Saudi Arabia Stomach Cancer Market by Healthcare Provider
9.4.5.3 U.A.E Stomach Cancer Market
9.4.5.3.1 U.A.E Stomach Cancer Market by Therapy
9.4.5.3.2 U.A.E Stomach Cancer Market by Healthcare Provider
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Stomach Cancer Market Overview
9.5.2 South and Central America Stomach Cancer Market Forecasts and Analysis
9.5.3 South and Central America Stomach Cancer Market Forecasts and Analysis - By Therapy
9.5.4 South and Central America Stomach Cancer Market Forecasts and Analysis - By Healthcare Provider
9.5.5 South and Central America Stomach Cancer Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Stomach Cancer Market
9.5.5.1.1 Brazil Stomach Cancer Market by Therapy
9.5.5.1.2 Brazil Stomach Cancer Market by Healthcare Provider
9.5.5.2 Argentina Stomach Cancer Market
9.5.5.2.1 Argentina Stomach Cancer Market by Therapy
9.5.5.2.2 Argentina Stomach Cancer Market by Healthcare Provider
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. STOMACH CANCER MARKET, KEY COMPANY PROFILES
11.1. ELI LILLY AND COMPANY
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. GLAXOSMITHKLINE PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. F. HOFFMANN-LA ROCHE LTD
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SANOFI
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVARTIS AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. OTSUKA HOLDINGS CO. LTD
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BRISTOL-MYERS SQUIBB
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. IMUGENE LIMITED
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MERCK KGAA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ONO PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Eli Lilly And Company
2. GlaxoSmithkline Plc
3. F. Hoffmann-La Roche Ltd
4. Sanofi
5. Novartis AG
6. Otsuka Holdings Co. Ltd
7. Bristol-Myers Squibb
8. Imugene Limited
9. Merck KGaA
10. Ono Pharmaceuticals
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book